Form 4 Filing for IMMUNIC, INC. - Officer/Director Transaction

Barclay Phillips, a director at IMMUNIC, INC., acquired 25,370 stock options on July 5, 2026. These options, with an exercise price of $14.80, are for the company's Common Stock. The options vest over one year from the grant date. The transaction was reported on July 7, 2026. This filing is classified as an Officer/Director Change.